In some cases CacyBP/SIP seems to function as a tumor suppressor, i.e., in gastric or renal cell carcinoma [12], and in other cases, such as pancreatic or colon cancer, as an oncogene [9, 13]. This evidence concerns the gene CACYBP and colonic neoplasm.